Literature DB >> 34014141

Understanding Retinal Vasculitis Associated with Brolucizumab: Complex Pathophysiology or Occam's Razor?

Ashish Sharma1, Nilesh Kumar1, Nikulaa Parachuri1, Sonali Singh2, Francesco Bandello3, Carl D Regillo4, David Boyer5, Quan Dong Nguyen6.   

Abstract

Entities:  

Keywords:  Brolucizumab; intraocular inflammation; occlusive vasculitis; retinal vasculitis

Year:  2021        PMID： 34014141     DOI： 10.1080/09273948.2021.1897628

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN： 0927-3948            Impact factor:   3.070


× No keyword cloud information.
  4 in total

1.  Retina: a unique subspecialty in the biosimilar landscape.

Authors:  Ashish Sharma; Nilesh Kumar; Nikulaa Parachuri; Carl D Regillo; Francesco Bandello; Baruch D Kuppermann
Journal:  Eye (Lond)       Date:  2022-02-21       Impact factor: 4.456

2.  Swept-source optical coherence tomography angiography of retinal occlusive vasculitis following brolucizumab administration: a case report.

Authors:  Eun Kyoung Lee; Baek-Lok Oh; Chang Ki Yoon; Un Chul Park
Journal:  BMC Ophthalmol       Date:  2022-06-03       Impact factor: 2.086

3.  Bilateral blindness after uneventful brolucizumab injection for macular degeneration.

Authors:  Ilan Barchichat; Michael Thiel; Oliver Job; Martin Schmid
Journal:  BMC Ophthalmol       Date:  2022-02-16       Impact factor: 2.209

4.  Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in vitro.

Authors:  Armin Wolf; Matus Rehak; Heidrun L Deissler; Catharina Busch
Journal:  Sci Rep       Date:  2022-07-21       Impact factor: 4.996
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.